Anne-Marie Duliege

CIK 1419579 · EVP & Chief Medical Officer · last filed 2019-03-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.79M

Companies

3

Total Filings

33

Lifetime Open-Market Net

-$2.96M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RIGL EVP & Chief Medical Officer 115,500 $32.85 $3.79M -$653.3K 12 2019-03-22
CCXI EVP, Chief of Strategic Dev. 0 $10.22 $0 -$23.4K 2 2014-11-20
AFFYMAX INC (AFFY) Delisted Chief Medical Officer 28,125 -$2.28M 19 2013-02-01

Recent Filings · Page 2 of 4

33 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-01-13 RIGL Sell (S) −5,000 -$12.0K EDGAR
2016-05-09 RIGL Grant (A) $0 EDGAR
2014-11-20 CCXI Sell (S) −4,970 -$23.4K EDGAR
2014-03-28 CCXI Grant (A) $0 EDGAR
2013-02-01 AFFYMAX INC (AFFY) Delisted Grant (A) +5,000 $0 EDGAR
2012-11-05 AFFYMAX INC (AFFY) Delisted Sell (S) −1,056 -$24.2K EDGAR
2012-10-12 AFFYMAX INC (AFFY) Delisted Sell (S) −9,704 -$232.9K EDGAR
2012-09-17 AFFYMAX INC (AFFY) Delisted Mixed -$324.0K EDGAR
2012-05-30 AFFYMAX INC (AFFY) Delisted Sell (S) −3,689 -$52.1K EDGAR
2012-02-02 AFFYMAX INC (AFFY) Delisted Grant (A) +8,125 $0 EDGAR
Showing 1120 of 33
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.